CSF3 and neoplasm: Recently, Allen and colleagues revealed that the presence of a tumor negatively impacts the systemic immune landscape, including a global suppression of T cell responses to tumor-unrelated antigen challenges as a result of increased IL-1 and G-CSF (3).